Biotage ABShs Aktie
Personal
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 463 | 497 | 517 | 674 | 673 |
| Umsatz pro Mitarbeiter in Mio. EUR | 2,36 | 2,48 | 3,03 | 2,76 | 3,05 |
Bilanz (in Mio. SEK) - Aktiva
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 752 | 774 | 1 031 | 1 447 | 1 323 |
| Summe Anlagevermögen | 683 | 1 218 | 1 308 | 3 484 | 3 781 |
| Summe Aktiva | 1 434 | 1 992 | 2 339 | 4 931 | 5 104 |
Bilanz (in Mio. SEK) - Passiva
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 444 | 621 | 702 | 1 274 | 991 |
| Summe Eigenkapital | 990 | 1 371 | 1 637 | 3 657 | 4 113 |
| Summe Passiva | 1 434 | 1 992 | 2 339 | 4 931 | 5 104 |
Adresse
| Vimpelgatan 5, 753 18 Uppsala | |
| Telefon | +46 (18) 56-59-00 |
| Fax | +46 (18) 59-19-22 |
| Internet | http://www.biotage.com |
Management
|
Anders Wikström
Executive Vice President-Operations |
|
Andrew F. Kellett
Chief Financial Officer |
|
Frederic Vanderhaegen
President & Chief Executive Officer |
|
Karen Lykke Sörensen
Director |
|
Kieran P. Murphy
Chairman |
|
Kugan Sathiyanandarajah
Director |
|
Lamberstam Philip
Director |
|
Lisa Egelrud
Executive VP-Quality Assurance Regulatory Affairs |
|
Magnus Nordstedt
Executive Vice President-IT & Digitalization |
|
Marc Hummersone
Chief Scientific Officer |
|
Mark Bradley
Director |
|
Maryam Poorafshar
Executive Vice President-Research & Development |
|
Peter von Ehrenheim
Director |
|
Petra Duprez
Chief Human Resources & Sustainability Officer |
|
Pär Lundgren
Director |
|
Scott Carr
Chief Operations Officer |
|
Torben Vedel Stahl Jörgensen
Director |
|
Åsa Hedin
Director |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.